Development of technology and study of optimized secreted products of stem cells for collaterogenesis

Simple item page
dc.contributor.authorSultankulov, B.
dc.contributor.authorMektepbayeva, D.
dc.contributor.authorZhiyenbay, Y.
dc.contributor.authorSeralin, A.
dc.contributor.authorAlibek, K.
dc.date.accessioned2015-10-27T06:04:33Z
dc.date.available2015-10-27T06:04:33Z
dc.date.issued2014
dc.description.abstractCell therapy using stem cells is a promising strategy for the treatment of ischemic diseases, nevertheless low viability of implanted cells, is one of the main problems limiting stem cell therapy. In addition, there is a risk of proliferation of the transformed cells in mesenchymal stem cells carrying properties of cancer stem cells. Using conditioned media from stem cells instead of stem cell themselves avoids the risks that may arise with the direct use of stem cells. Conditioned media from various stem cells contains a different number of cytokines and growth factors, necessary for the natural process of new vessel formation.ru_RU
dc.identifier.isbn9786018046728
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/507
dc.language.isoenru_RU
dc.publisherNazarbayev Universityru_RU
dc.subjectcellru_RU
dc.subjectimplanted cellsru_RU
dc.subjectcell therapyru_RU
dc.subjectcytokinesru_RU
dc.subjectpolymerru_RU
dc.subjectnanoparticlesru_RU
dc.subjectangiogenesisru_RU
dc.subjecttissueru_RU
dc.subjectallogeneic transplantationsru_RU
dc.subjectclinical applicationru_RU
dc.titleDevelopment of technology and study of optimized secreted products of stem cells for collaterogenesisru_RU
dc.typeAbstractru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
DEVELOPMENT OF TECHNOLOGY.pdf
Size:
81.93 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

NU Research Week - II